CSRNP1 and perinatal asphyxia: CSRNP1 has only been identified as a key gene associated with neonatal hypoxic-ischemia brain damage by RNA sequencing and single-nucleotide polymorphism screening, and also a candidate target for hypoxic-ischemic encephalopathy therapy, but lacks further investigations [26].